INTRODUCTION
Various culture vessels are used in the performance of in vitro fertilization (IVF; organ culture dishes, petri dishes, tissue culture tubes), while varying volumes of culture media (microdrops to 3.0 ml) are used for oocyte insemination (1) . The choice of which culture vessel and insemination medium volume are used is controlled, at least in part, by practical aspects. For example, the amount of time saved and the reduced risk of losing or damaging the oocytes/embryos are two advantages of using microdrops in a petri dish versus tissue culture tubes. However, these advantages may be nullified if the outcome (i.e., fertilization, embryo quality, decreased incidence of polyploidy, etc.) favors the tissue culture tube. Preliminary results (2) indicate that inseminating and culturing in microdrops and tissue culture tubes demonstrate similar outcomes, but the data are limited in the number of oocytes evaluated and lack some of the stringency of methodology that would help to discern a true difference between oocyte insemination and culture in the two culture vessels.
The purpose of this study is to compare results of fertilization and development of human oocytes/ embryos when insemination and culture are carried out in tissue culture tubes or microdrops which contained an equivalent number of motile sperm.
MATERIALS AND METHODS
Techniques used for controlled ovarian hyperstimulation and transvaginal oocyte retrieval have been described in detail elsewhere. (3) A total of 733 oocytes from 54 IVF patients was included in this study. Each patient underwent a single IVF cycle. The patient population included 21 patients (39%) with endometriosis as their primary diagnosis, 14 patients (26%) with tubal factor, 7 patients (13%) with ovulatory dysfunction, 3 patients (6%) with male factor, 3 patients (6%) with uterine factor, 3 patients (6%) with pelvic adhesions, 2 patients (4%) with recurrent ectopics, and i patient (2%) with unexplained infertility. The average age of the female patients was 33 years old, with a range of 24 to 46 years.
Oocyte culture techniques performed routinely in the Assisted Reproductive Technology (ART) Laboratory at the Greenville Hospital System were used in this study. Oocytes in the tissue culture tubes were exposed to 100,000 motile sperm/tube, whereas the oocytes in the microdrops were exposed to 5000 motile sperm/drop. (A total of 5000 sperm per 50 ~1 is equivalent to 100,000 sperm per 1.0 ml.) All sperm used in this study were obtained from fresh ejaculates and were prepared using a swim-up technique. (3) Descriptive statistics for the semen specimens used are presented in Table I . All oocytes were stripped of cumulus cells and observed for evidence of fertilization approximately 16 hr post-insemination.
Embryo quality was determined by the cell stage (number of blastomeres) and the cell grade (scored on a scale of 1 to 5, with 1 being the best, and based on the percentage of fragmentation, the symmetry, uniformity, and density of the blastomeres, and the thickness of the zona pellucida) for each embryo. Embryo quality was the primary determinant in selecting embryos for transfer.
Whether cryopreservation of zygotes was performed was determined by the number of zygotes available and the willingness of the IVF patients to participate in the procedure.
The term "polyploid" was assigned to any zygote demonstrating three or more pronuclei.
Data were evaluated using the two-tail Fisher's exact test.
RESULTS
While the fertilization rate was slightly higher in the microdrops than in the tissue culture tubes (67.4 vs 64.7% ; Table II) , the values were not significantly different (P = 0.437). Five patients laad 0% fertilization in the tubes and the dishes.
Oocytes from two patients fertilized in one treatment and failed to fertilize in the other. The first patient had only one of six oocytes fertilize, with the fertilization occurring in the microdrop treatment. The second patient had only one of two oocytes fertilize and fertilization occurred in the tissue culture tube treatment.
The average cell stage and embryo grade were not different for embryos produced in either the tubes or There was no significant difference (P = 0.379) in the number ofpolyploid embryos produced in the tubes (n = 19) versus the microdrops (n = 14). The rate of polyploidy for the tissue culture tubes was 5.2%, compared to 3.8% for the microdrop treatment.
DISCUSSION
Our conclusions support the general findings of others (2), although differences were noted in the methodologies used. For example, we maintained an equivalent number of motile sperm for insemination regardless of the volume of media in the culture vessel, whereas the other researchers (2) utilized a two-to fivefold increase in sperm numbers in favor of the microdrops. There is some indication that Fioretino and co-workers may have used 7-to 10-day-old semen parameters to make determinations for the amount of sperm that was to be added to each oocyte. Our protocol called for equal treatment of the oocytes regardless of any previous semen analysis results. Also, Fiorentint and co-workers used frozen/thawed sperm to derive some of their conclusions whereas we used only fresh semen.
Despite these major methodological differences in sperm management, the fertilization outcomes for the different culture vessels were essentially the same and our results provide support from a second laboratory that microdrops performed at least as well as tissue culture tubes in supporting fertilization and overall embryo development using the techniques described above. Our study had a statistical power of 80% to detect at least a 10% difference in the two groups, assuming a 65% fertilization rate in the tissue culture tube group. Furthermore, the use of microdrops saves a substantial amount of time during oocyte/embryo handling procedures and greatly reduces the risk of losing or damaging the oocytes/embryos.
CONCLUSIONS
Our laboratory has corroborated previously published work demonstrating that tissue culture tubes and microdrops perform equally well for in vitro fertilization and culture of human oocytes and embryos.
William R. Boone 
~TRODUCTION
The transition to menopause is commonly referred to as the climacteric. During this time, a number of events occur prior to complete cessation of menses. Subtle changes include a diminution in the number of oocytes, elevations in serum gonadotropins, specifically follicle stimulating hormone (FSH), and lower levels of sex steroids (1) .
Age has long been known to be associated with a natural decline in fertility (2) . This relationship has been noted in patients undergoing assisted reproduction (ART) (3). However, there is individual variation within the population with respect to response. For instance, occasional older women respond to controlled ovarian hyperstimulation (COH). Conversely younger women may experience unexpectedly poor responses.
Serum FSH has been demonstrated to have prognostic predictive value for women undergoing ART and, when found to be abnormal, is a more sensitive marker of ovarian reserve than age alone (4). However, both age and serum hormone values need to be considered in evaluating the overall prognosis for undergoing therapy.
Since age and serum FSH are independent predictors of cycle quality and outcome, we hypothesized that younger-and older women with elevated FSH attempting COH may demonstrate different clinical responses. Patients with elevated baseline hormone levels planning to undergo in vitro fertilization are typically canceled. However, we offer patients with a diminished ovarian reserve (elevated FSH levels) COH and IUI prior to moving to donor gametes since it is less invasive, is less costly, and occasionally results in pregnancy. We were interested in reviewing their
